The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting

NCT03034694 | Completed

• 1 other identifier: 2015H0393
• Study Type: interventional
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

The effect of teledermatology on length of hospital admission, length of stay, 30 day readmission rate, and antibiotic use in patients presenting with cellulitis vs pseudocellulitis in an academic emergency department setting.

Conditions

Cellulitis

Outcome Measures

Primary Outcomes (1)

• Length of Hospitalization

  60 Days

Secondary Outcomes (2)

• Readmission rate

  30 Days

• Frequency/Use of antibiotics

  30 days

Study Arms (2)

Routine Care

PLACEBO COMPARATOR

The first group will be randomized to routine care of receiving or not receiving a dermatology consult in the hospitalized setting based on the clinical decision of the hospitalist. The patients will see the research coordinator who will take images and for a teledermatology assessment, however, these assessments will not be placed in the chart and the treating hospitalist will not know.

Other: Routine Care

Teledermatology INtervention

EXPERIMENTAL

The second arm will be patient randomized to teledermatology intervention. These patients will be imaged by the research coordinator, then the assessment will be placed in the chart for the hospitalist to see although final treatment decisions are still made by the hospitalist.

Other: teledermatology consult

Interventions

teledermatology consult OTHER

teledermatology consult

Teledermatology INtervention

Routine Care OTHER

The patient will undergo imaging but this report will not be put into the chart.

Routine Care

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Over 18
• Admission for cellulitis-like symptoms, including but not limited to the following: tenderness, redness, swelling, expansive lesion

You may not qualify if:

• pregnant
• prisoner

Sponsors & Collaborators

• Ohio State University: lead

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Cellulitis

Condition Hierarchy (Ancestors)

Skin Diseases, Infectious; Infections; Suppuration; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Inflammation; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Benjamin H Kaffenberger, MD

  OSU Dermatology

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: DIAGNOSTIC
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Model Details: Routine Care vs The use of teledermatology

Study Record Dates

• First Submitted: June 4, 2016
• First Posted: January 27, 2017
• Study Start: January 1, 2016
• Primary Completion: January 1, 2018
• Study Completion: January 1, 2018
• Last Updated: January 18, 2018

Record last verified: 2018-01

Data Sharing

• IPD Sharing: Will share

Locations

US (1)